Navigation Links
Plant Health Scientists Reiterate Support of Biotechnology on World Food Day

ST. PAUL, Minn., Oct. 18, 2013 /PRNewswire-USNewswire/ -- Given the continuing debate about biotechnology, the Council of the American Phytopathological Society (APS) refined its position on the topic this week, as three pioneers of agricultural biotechnology received the World Food Prize. APS, the world's largest organization of plant health scientists, represents nearly 5,000 members in 90 different countries. Citing enormous potential benefits for management of plant diseases offered by this technology, APS reiterated its support and opposed mandatory labeling of food derived from genetically modified (GM) plants.

"Biotechnology today is a valuable tool for improving plant health, food and feed safety, and sustainable gains in plant productivity," stated APS President George Abawi. "As has been discussed this week during the Borlaug Summit and the World Food Prize, biotechnology will continue to be an extremely important part of the toolbox for managing plant health."

While strongly supporting transparent science-based regulation of agricultural products, APS has long opposed regulating food, feed, and fiber products solely on the basis of the particular technology used to create these products.

"Current scientific evidence supports the conclusion that GM plants pose no greater safety risk than traditionally bred plants. Labeling GM could be very confusing to consumers," suggested Abawi, "and could reduce the availability and use of this technology for the management of plant diseases."

For a copy of the complete APS Position Statement on the Compulsory Labeling of Plants and Plant Products Derived from Biotechnology, visit

The American Phytopathological Society (APS) is a nonprofit, professional scientific organization dedicated to the study and control of plant disease and has 5,000 members worldwide.

SOURCE American Phytopathological Society
Copyright2012 PR Newswire.
All rights reserved

Related biology technology :

1. Case Report Published in the Journal Perfusion on 14-Year-Old Pediatric Patient Bridged to Transplant with SynCardia Total Artificial Heart
2. A Record 125 SynCardia Total Artificial Hearts Implanted by Surgeons Worldwide So Far in 2013
3. Market Study MBT - The European Market for Mechanical Biological Treatment Plants
4. Nasseo’s TiArray™ Dental Implant System Receives FDA Approval
5. Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants
6. UK’s 1st SynCardia Total Artificial Heart Patient Bridged to Transplant at Papworth Hospital
7. CABI Boosts Contribution to Research4Life with 77 New Titles on Agriculture, Plant and Veterinary Science
8. Mendel Biotechnology to sell its subsidiary, Mendel Plant Sciences
9. Suria Plastic Surgery Announces an Open House at Their Plantation, Florida Office
10. MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
11. Midwest Specialty Distribution Plant Expanding as Companies Focus on Sales and Distribution Issues
Post Your Comments:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):